Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Adjuvant / neoadjuvant therapy of operable NSCLC in 2023

Current standard of care in adjuvant / neoadjuvant therapy of operable NSCLC

Date

23 Oct 2023

Session

Adjuvant / neoadjuvant therapy of operable NSCLC in 2023

Topics

Clinical Research;  Surgical Oncology

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Heather Wakelee

Authors

H. Wakelee

Author affiliations

  • Medicine/oncology Department, Standford University, 94305 - Stanford/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: Adjuvant / neoadjuvant therapy of operable NSCLC in 2023

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.